| __timestamp | Bio-Techne Corporation | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 30945000 | 1488000000 |
| Thursday, January 1, 2015 | 40853000 | 1525000000 |
| Friday, January 1, 2016 | 45187000 | 2111000000 |
| Sunday, January 1, 2017 | 53514000 | 1848000000 |
| Monday, January 1, 2018 | 55329000 | 1213000000 |
| Tuesday, January 1, 2019 | 62413000 | 1010000000 |
| Wednesday, January 1, 2020 | 65192000 | 997000000 |
| Friday, January 1, 2021 | 70603000 | 967000000 |
| Saturday, January 1, 2022 | 87140000 | 838000000 |
| Sunday, January 1, 2023 | 92493000 | 953000000 |
| Monday, January 1, 2024 | 96664000 | 998000000 |
Igniting the spark of knowledge
In the competitive world of pharmaceuticals and biotechnology, innovation is the key to staying ahead. Teva Pharmaceutical Industries Limited and Bio-Techne Corporation are two industry leaders, each with a unique approach to research and development (R&D) investment. Over the past decade, Teva has consistently outspent Bio-Techne, with R&D expenses peaking at nearly 2.1 billion USD in 2016. In contrast, Bio-Techne's investment has shown a steady upward trend, growing by approximately 212% from 2014 to 2023. While Teva's spending has fluctuated, Bio-Techne's commitment to innovation has been unwavering, with a notable increase of 50% from 2019 to 2023. This data highlights the strategic differences in how these companies prioritize innovation, with Teva focusing on large-scale investments and Bio-Techne emphasizing consistent growth. As the industry evolves, these investment strategies will play a crucial role in shaping their future success.
Comparing Innovation Spending: Merck & Co., Inc. and Bio-Techne Corporation
Comparing Innovation Spending: Novartis AG and Bio-Techne Corporation
Teva Pharmaceutical Industries Limited or Intra-Cellular Therapies, Inc.: Who Invests More in Innovation?
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and Bio-Techne Corporation
Who Prioritizes Innovation? R&D Spending Compared for Teva Pharmaceutical Industries Limited and Jazz Pharmaceuticals plc
R&D Spending Showdown: Teva Pharmaceutical Industries Limited vs PTC Therapeutics, Inc.
R&D Insights: How Bio-Techne Corporation and Lantheus Holdings, Inc. Allocate Funds
Bio-Techne Corporation or Corcept Therapeutics Incorporated: Who Invests More in Innovation?
Research and Development Investment: Bio-Techne Corporation vs CRISPR Therapeutics AG
Research and Development Expenses Breakdown: Bio-Techne Corporation vs Perrigo Company plc
Analyzing R&D Budgets: Bio-Techne Corporation vs MorphoSys AG
Analyzing R&D Budgets: Bio-Techne Corporation vs Arrowhead Pharmaceuticals, Inc.